FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease1 report from 1 outlet in 1 language · first reported 2026-09-28 16:59 UTC · updated 2026-09-28 16:59 UTC · JSONHealthUnited States Food and Drug AdministrationtavapadonParkinson's diseaseReportsFDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Diseasepharmacytimes.com · en · 2026-09-28 16:59 UTC